Stay updated on CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check9 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.2%
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a phase III study evaluating CHF 6532 for severe eosinophilic asthma, while retaining some basic study information such as the study's location and design aspects like being placebo-controlled and double-blind.SummaryDifference39%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check96 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.